Mutations that pathogens accumulate over time can be used to reconstruct their transmission history. In theory, the same principles that are used to track spread across the globe and between individuals can inform our understanding of how M. tuberculosis spreads within the lungs and throughout the body 9, 10 . Although M. tuberculosis primarily causes lung infections, it can disseminate to extrapulmonary organs, particularly in subjects who are co-infected with HIV. Understanding how M. tuberculosis diversifies and spreads within individuals is crucial to outbreak tracing 11 , clinical diagnosis of resistance [12] [13] [14] and design strategies to minimize de novo emergence of antibiotic resistance [15] [16] [17] .
Here we conducted a postmortem study in KwaZulu-Natal, South Africa, to capture the spatial diversity of M. tuberculosis within each person ( Fig. 1) . Inclusion criteria included tuberculosis as cause of death, suspected disseminated infection and fewer than 4 d of antitubercular treatment (Online Methods). Ninety-six of the 100 subjects enrolled were HIV positive, reflecting the high rate of HIV positivity among those dying from tuberculosis in the province. For each subject, a minimally invasive autopsy was performed, and specimens were collected from each of six lung sites (three regions within each lung; Supplementary Table 1) , as well as from the liver and spleen. Each lung biopsy site was processed individually, whereas multiple biopsies from the other organs were pooled to form a single site per organ. Endotracheal aspirate, a proxy for what might have been detectable from a sputum specimen, was also collected. Specimens were cultured on a solid medium to select for M. tuberculosis. We focused on 44 subjects who had positive cultures for at least one lung site and at least one extrapulmonary site. Of these, all but two were HIV positive (Supplementary Table 2) .
A total of 2,693 M. tuberculosis samples from 329 sites were analyzed for single-nucleotide polymorphisms (SNPs) at the whole-genome level (Supplementary Table 3 ). For the first 12 subjects, the colonies that grew on the solid medium were scraped into a single tube, resulting in one DNA sample per site. For the remaining subjects, up to 15 individual colonies from each site were processed as separate samples (in many cases, colonies were found to be formed by multiple cells). Genomic libraries were sequenced on the HiSeq platform to an average of 178× for scrape samples and 59× for colony samples. Reads were aligned to an approximate ancestral genome of the M. tuberculosis complex 3 , allowing inference of derived and ancestral alleles. Covariation of mutation frequencies across samples from each subject distinguished pre-existing polymorphisms owing to mixed infection from de novo mutations (Online Methods; Supplementary Fig. 1 ).
We then used a constraint-based method to infer individual genotypes in nonclonal samples (Supplementary Fig. 2 ).
Four subjects had mixed infections, providing a prevalence estimate (9%) consistent with high-endemic areas 15, 18, 19 . These subjects were identified by the average mutational distance of their M. tuberculosis population to its most recent common ancestor (referred to as dMRCA; Online Methods; Fig. 2a) . Given the M. tuberculosis molecular clock rate of ~0.3-0.5 SNPs/year 5, 8, 20 , these subjects had dMRCA values consistent with those of mixed infection (201-439 SNPs/cell), whereas all others had values of fewer than 5 SNPs/cell. In two of these four cases, the minority strain was detected at low frequency across samples (5% and 11%), highlighting the importance of deep sampling for the detection of mixed infections.
Mutations appearing de novo showed evidence of purifying selection. The number of de novo mutations detected varied considerably across subjects (median 8.5 SNPs; range 0-59; Fig. 2b ) and was somewhat dependent on the number of specimens ( Supplementary  Fig. 3a ), but it was generally too low for selection to be analyzed on a subject-by-subject basis. Considering all of the de novo mutations together, the relative proportions of different nucleotide-tonucleotide mutations closely matched those of mutations between subjects ( Supplementary Fig. 4 ). De novo mutations had fewer amino acid-changing mutations than expected under a model of neutral evolution (normalized ratio of nonsynonymous to synonymous mutations (dN/dS) = 0.78; P < 0.01; Online Methods), similar to mutations observed between subjects (dN/dS = 0.80, P < 0.001). These data suggest that purifying selection, which has also been identified from between-patient comparisons 21, 22 , does not require patient-to-patient transmission but can occur within each subject.
De novo mutations led to sublineages that coexisted for many years in some patients. When focusing on single-strain infections, dMRCA estimates varied considerably across subjects (range 0-5 SNPs/cell, consistent with diversification for 0-16 years; Fig. 2a ) and were not sensitive to the number of samples (Supplementary Fig. 3c,d) . Some subjects had dMRCA values consistent with many years of within-patient diversification, yet most subjects had much lower dMRCA estimates (median 0.24 SNPs/cell, consistent with diversification for <1 year), consistent with the fact that immunocompromised subjects are likely to have fulminant courses of disease. Subjects who were HIV seronegative or diagnosed with HIV infection only post mortem had higher dMRCA values on average (six subjects; median 1.0 SNP/cell; consistent with diversification for 2.2-3.4 years; P < 0.02 by Wilcoxon rank-sum test), consistent with a longer duration of infection in patients who are not immunocompromised 23, 24 . For all of the subjects with de novo mutations, even when the dMRCA value was small, diversification led to coexisting short-branched sublineages (Fig. 2c) .
The diversity arising from de novo mutation and mixed infections was heterogeneously distributed across lung sites. In subjects with mixed infections, strain distribution varied considerably across sites, often with only one strain detected per lung site (Fig. 3a) . Considering only de novo mutations, cells from the same site were significantly more similar to one another than to cells from different sites (P < 0.05 by one-sided two-sample t-test for 17/30 subjects with multiple sites and at least one de novo mutation; Fig. 3b ). Inspection of intrapersonal phylogenies further revealed that minority genotypes can be localized to a single site and that some sites were dominated by minority sublineages not seen elsewhere within the lungs (for example, Fig. 3c ). This spatial heterogeneity was neither universal nor long-lived; many new mutations were shared across lung sites, and no long branches were unique to a single lung or site. These results are consistent with reports of spatial heterogeneity in other lung infections 9 and in M. tuberculosis infections of HIV-negative individuals [25] [26] [27] . Whatever the mechanism, this heterogeneity meant that many de novo mutations and strains infecting subjects' lungs were undetected in tracheal aspirate samples ( Fig. 3d and Supplementary Fig. 5 ). Although sputum samples were not available, this suggests that spatial heterogeneity can compromise the reliability of antibiotic-resistance profiling and other assays performed even on the entire diversity within respiratory samples 28 . Unexpectedly, the genetic distance between cells from different sites, both within the lungs and between organs, did not depend on spatial proximity. Cells from sites in different lungs (right versus left) were, on average, no more different than cells taken from sites in the same lung (Fig. 4a) . Furthermore, two cells from different organs were no more different than two cells taken from different lung sites ( Fig. 4b and Supplementary Fig. 6 ). Moreover, genotypes from the liver or spleen sites did not cluster phylogenetically, suggesting dissemination of multiple genotypes to each of these organs (Fig. 4c) . To compare rates of transmission between organs and within the lungs, we estimated the number of transmitted genotypes between the lungs and extrapulmonary organs inferred by their joint phylogeny ( Fig. 4c ; Online Methods). We inferred multiple transmitted genotypes between the lungs and extrapulmonary organs for many subjects (Fig. 4c,d ). These multiple genotypes might result from a single transmission event involving multiple genotypes or from repeated transmission events 29 ; we note that the detection of different genotypes in the liver and spleen from the same individual suggests multiple independent transmission events. Notably, the number of genotypes transmitted from the lungs to extrapulmonary sites was as high as the number of transmissions between different lung sites (Fig. 4d) .
The similar patterns of migration within and between organs suggest that dissemination of M. tuberculosis across the lungs of these subjects is no easier than dissemination across organs. These results support the hypothesis that both intra-lung and inter-organ spread are mediated by similar dissemination mechanisms, such as by macrophage trafficking through the bloodstream or by other mechanisms of hematogenous spread [30] [31] [32] . It would be interesting to investigate the generality of these results in subjects with less advanced disease or without HIV.
The diversity of genotypes within individuals and their stratification across the body have implications for outbreak tracing. A major impetus for whole-genome sequencing of M. tuberculosis, as well as other pathogens, has been to identify transmission links between individuals. Although future approaches will incorporate the pathogen diversity within each person [33] [34] [35] , current approaches establish an epidemiological linkage between people if the mutational distance between single samples from each patient is below a set threshold 7, 8, 22, 36 . Considering all of the genotypes of M. tuberculosis within a subject, 20% of subjects harbored genotypes separated by more than a common threshold of 5 SNPs 8 (Supplementary Table 2 ; 9% emerging from multiple-strain infection), and 11% harbored genotypes separated by more than an alternative threshold of 12 SNPs 37 . These estimates may be even greater when considering longerduration infections, such as those of HIV-negative individuals. Although the thresholds chosen will depend on the mutation-detection sensitivity unique to each study, the frequency of substantial withinpatient distances adds weight to the mounting evidence 11 (d) For each subject, the number of de novo mutations detected within the subject is plotted against the number of de novo mutations detected within only the tracheal aspirate. Low-abundance mutations were the most likely to be missing from the tracheal samples ( Supplementary Fig. 5a,b) . A small offset was added to improve visualization (up to 0.5 mutations; same value added in x and y). against ruling out epidemiological links on the basis of mutational thresholds between single samples. This study represents the first large-scale genomic investigation of M. tuberculosis diversity across the human body. Extensive sampling from multiple body sites and detection of minor alleles within each sample shows that even the notoriously slowly evolving M. tuberculosis presents substantial within-patient diversity. The distribution of this diversity across the body suggests that, at least in people with HIV, dissemination within the lungs follows a similar mechanism as dissemination from the lungs to extrapulmonary organs. In total, these findings highlight the potential of whole-genome sequencing to make inferences about the history of individual bacterial infections from the diversity surveyed at a single time point. We anticipate that future studies will extend these approaches to address open questions about M. tuberculosis and other pathogens, including the contribution of spatial heterogeneity to the evolution of antibiotic resistance and to the dynamics of dormancy and reactivation.
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Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Genotypes are indicated as 'within an organ' with a colored box in the corresponding column if they were found at >20% frequency in at least two samples from that organ. Potential transmission events between the lungs and extrapulmonary organs are identified by mutations shared across organs and indicated with a double-sided arrow of the corresponding color. (d) For each subject, the minimum number of transmitted genotypes to the liver and/or spleen from the lungs was inferred (y axis) and compared to the mean of the minimum number of transmitted genotypes to each lung site from the rest of the lungs (averaging across sites; x axis). Simulations were used to normalize for sampling efforts (Online Methods). Error bars indicate the s.e.m. across lung sites. A small offset was added for visibility (up to 10%; same value in x and y).
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Study cohort. Subjects were eligible for inclusion in our study if they died while at Edendale Hospital, were age 20 or over, were on antitubercular treatment for fewer than 4 d before death, and were either smear positive for acid-fast bacilli or had at least one focal process compatible with tuberculosis without an alternative diagnosis. The number of subjects studied was determined on the basis of feasibility. Subjects were de-identified before DNA analysis, and mutation calling was performed by researchers who were blinded to subject information.
Sample collection. Following informed consent by family members under a protocol approved by the institutional review board at University of KwaZuluNatal, a minimally invasive autopsy was performed for each subject. Briefly, samples from three lung sites were collected from each side-at the second, fourth and sixth intercostal spaces. A new sterile needle was used at each site (see Supplementary Note for more detail). Specimens were stored on ice and transported to the University of KwaZulu-Natal in Durban. Participants who were not documented in the case notes to be HIV seropositive were tested post mortem using a lateral-flow ELISA assay. Subject information is listed in Supplementary Table 2 . Cause of death for all subjects was culture-confirmed disseminated tuberculosis. Biopsy specimens were cut into small pieces and decontaminated using Petroff 's method 40 (to enrich for M. tuberculosis). Endotracheal aspirate specimens were decontaminated with a 4% N-acetyl-l-cysteine (NALC) in NaOH solution. 500 µl of the decontaminated specimen was inoculated into a mycobacteria growth indicator tube (MGIT), and 100 µl was spread on three separate 7H11 plates 41 to select for M. tuberculosis. For the first 12 subjects, the colonies (which represented the microbial diversity of the sample) on these three plates were scraped into a single tube for DNA analysis. For the remaining cultures, up to five single colonies, demonstrating morphological variation, were selected from each plate (for a maximum of 15 colonies per specimen). Each colony was then subcultured onto dedicated 7H11 plates and incubated for 3 weeks at 37 °C under aerobic conditions. Antibiotic resistance testing. Phenotypic antibiotic susceptibility testing was performed on all decontaminated specimens. The modified proportion method was used for antibiotic susceptibility testing. Positive MGIT tubes from each specimen were used to set up the antibiotic susceptibility tests. Tubes were confirmed to be uncontaminated and were incubated for an additional 24-48 h after becoming instrument positive before the test was performed. 7H11 cultures that had been incubated for 3 weeks were used in the event the MGIT cultures were found to be contaminated or to confirm resistance.
Quadrant 7H10 agar plates that comprised a control (antibiotic-free) quadrant and antibiotic-containing quadrants were used. The following concentrations were used: 1 µg/ml isoniazid, 1 µg/ml rifampicin, 7.5 µg/ml ethambutol, 2 µg/ml streptomycin, 2 µg/ml ofloxacin, 5 µg/ml kanamycin, 5 µg/ml ethionamide and 10 µg/ml capreomycin. Cultures were diluted so as to obtain approximately 100 colony-forming units (CFU) on each quadrant and seeded onto each quadrant. The plates were sealed in CO 2 -permeable bags and incubated at 37 °C and 5% CO 2 for 1 week, and then under aerobic conditions for an additional 2 weeks. Cultures with control M. tuberculosis strains (H37Rv and A169) were set up in parallel. Antibiotic-containing quadrants with CFU > 1% of the CFU on the control quadrant were interpreted as being antibiotic resistant. Either no growth or CFU < 1% of that of the control quadrant was interpreted as being antibiotic susceptible. Cultures were read in a double-blind manner.
No significant variation was found across specimens from a given subject. Specimens from subjects P4, P9 and P12 were multidrug resistant; specimens from P16 were rifampicin resistant, and all others were susceptible to all drugs tested (Supplementary Table 2) . DNA extraction. DNA was extracted using the N-acetyl-N,N,N-trimethyl ammonium bromide (CTAB) method 42 . M. tuberculosis colonies were scraped from agar, resuspended into 500 µl of water in a microcentrifuge tube and heat-killed for 30 min at 80 °C. 70 µl 10% sodium dodecyl sulfate and 50 µl proteinase K (10 mg/ml stock solution) were added, and the solution was incubated for 1 h at 60 °C using a thermomixer on 'low-mode' shaking. Samples were removed from the thermomixer, and 100 µl 5 M NaCl (preheated to 60 °C) was added and mixed thoroughly by hand inversion. 100 µl 10% CTAB (preheated to 60 °C) was added, and the solution was mixed by hand inversion. Tubes were then incubated at 60 °C for 15 min (thermomixer on low-mode shaking). 700 µl chloroform:isoamyl alcohol (24:1) was added, and the solution was mixed by hand inversion. Tubes were then centrifuged for 10 min at 13,000 r.p.m. The upper (aqueous) phase was transferred to a tube with 700 µl of cold isopropanol and mixed by hand inversion. DNA was precipitated by freezing at -20 °C for at least 30 min and centrifugation for 10 min at 13,000 r.p.m. Tubes were drained, and the pellet was washed with 80% ethanol followed by centrifugation for 5-10 min. These were then drained, and the pellet was allowed to dry. DNA was suspended in 55 µl of 10 mM Tris with 1 mM EDTA (TE buffer).
Illumina sequencing and mutation identification. Genomic libraries were constructed and barcoded using a previously described modified version of the Illumina Nextera protocol 43 . Genomic libraries were sequenced on the Illumina HiSeq 2000 platform by Macrogen using paired-end 100-bp reads. Reads were aligned to a modified H37rv reference genome in which each nucleotide reflects this ancestor of the M. tuberculosis complex 3 (provided by Iñaki Comas). The limited mutation distance of all extant M. tuberculosis to this ancestor (<0.05% of the genome) and limited recombination in M. tuberculosis 3 gives us confidence that each difference from this reference that passed our conservative filters (Supplementary Note) represents a newly derived mutation. Standard approaches were used for read-filtering and alignment 44 . Average coverage for each sample is listed Supplementary Table 4 .
Potential cross-contamination or mislabeling events were identified by the presence of multiple mutations that were not found in any other sample from that subject and/or the multiple mutations found in samples from different subjects processed on the same plate. We identified 68 such potentially contaminated samples. New, repeated genomic libraries were prepared for 40 of these 68 samples. In 31 cases, the sequencing results from the duplicate matched more closely with those of other samples from that subject, and the duplicate was used for analysis. In nine cases, the duplicate also showed evidence of contamination, and the two replicates of the sample were discarded (for a total of 37 discarded samples out of 2,730; 1.4%). In our final data, subjects had distinct strains (Supplementary Fig. 7 ). Because some of these samples may have been discarded in error, some true mixed infections may have been called as simple infections.
Many single-colony samples from subjects with mixed infections had hundreds of mutations at intermediate frequencies-suggesting that cells from different strains were comingled in a single colony (Supplementary Fig. 1c ; consistent with the cording phenotype of M. tuberculosis 45 ). We therefore searched for both fixed and polymorphic mutations within each sample, using a series of filters and statistical tests to distinguish false positives (for example, alignment and sequencing errors) from real polymorphisms 44 . Additional filters regarding the proportion of samples in each subject with a polymorphism were also used to remove notoriously problematic sites, such as genes encoding members of the proline-glutamate and proline-proline-glutamate (PE and PPE) families 46 (see Supplementary Note for details). Among these filters, polymorphic mutations were required to be supported by at least 10% of the reads and supported by at least four reads on each strand. As a consequence, rare variants may not have been detected, particularly in cases in which few samples were available per site.
For each polymorphic position that met the filtering criteria in at least one sample, raw reads were used to determine the allele frequency across samples from that subject. The 518 de novo mutations found, and their distribution across samples, are listed in Supplementary Table 4 . Mutations and genes were annotated according to the H37rv sequence (NC_000962.3). None of these mutations are known to be associated with antibiotic resistance 47 . dN/dS. Calculations for dN/dS, the ratio of nonsynonymous mutations to synonymous mutations divided by the ratio under a neutrality, were performed normalizing for the spectrum of mutations observed as previously described 44 .
P values for depletion of nonsynonymous mutations were calculated according to the binomial cumulative distribution function.
Identification of polymorphisms arising from multiple-strain infection.
Mutations carried by each of the infecting strains co-vary across samples with one another and inversely co-vary with mutations from the other strain 48 . Mutations arising from multiple-strain infection are defined by their contribution to the primary principal component (PC1) in a principal component analysis (PCA) of the mutation-frequency matrix. De novo mutations are identified as those without a significant contribution to PC1 (absolute value < 0.015, cutoff determined empirically; Supplementary Fig. 1 ). Previously described SNP markers were used to assign each strain to a global lineage 49 .
Estimation of dMRCA. The average mutational distance across cells in a subject's M. tuberculosis population to its most recent common ancestor, referred to as dMRCA, was calculated as the sum of the mutation frequencies at each polymorphic position called within the subject 44 . To normalize for sampling efforts, the dMRCA value was first calculated across samples from each specimen, and these values were averaged for each subject. For subjects who were previously diagnosed with HIV, the mean value of dMRCA was 0.42 SNPs/cell, and for subjects who were HIV negative or diagnosed post mortem, this mean was 1.8 SNPs/cell ( Fig. 2a and Supplementary Table 2) .
Interpretation of dMRCA as 'time of infection' assumes that these subjects were infected with a single genotype; if subjects were infected by multiple closely related genotypes, then these estimates are inflated. Alternatively, these estimates may be underestimations if mutations have swept the subject's diversity since infection due to adaptation or bottlenecks (drift). Estimates of dMRCA for subjects with multiple-strain infection are minimal estimates because the strict mutation caller was optimized for detecting de novo mutations. Other potential sources of error include: Poisson error in the number of mutations accumulated in each lineage since each subject's MRCA, underestimation due to limited sensitivity in detecting mutations, overestimation due to false positives, incorrect designation of ancestral versus derived alleles, and underestimation due to incomplete sampling of the diversity within each subject.
Genotype identification and phylogenetic inference. We used a conservative algorithm to infer a minimal set of distinct genotypes within each subject based on the assumptions that genotypes are shared across samples from each subject and that each SNP occurred only once within a subject (strict parsimony). A direct consequence of the strict parsimony assumption is that two mutations at high frequency (majority) in the same sample must coexist on the same genotype 50, 51 . For each sample within a subject, starting with the most homogenous and covered samples, high-frequency polymorphisms were matched with previously identified genotypes, or if no such match was made, then the polymorphisms found at high frequency were used to define a new genotype (Supplementary Fig. 2 ). Some de novo mutations could not be confidently assigned to a genotype and were omitted; combined with our stringent mutation caller, this approach produced conservative phylogenies in which some genotypes were not identified or called with fewer mutations than they really have. After genotypes were identified, each sample was then assigned to one or more genotypes. We note that our algorithm will not work well in cases where parallel nucleotide evolution is expected or where pure samples are not available, and that the cutoffs in our implementation may need to be adjusted for different use cases (Supplementary Note).
Pairwise genetic distances. We calculated the average pairwise distance between cells in different samples, considering the frequency of each mutation f at each confident polymorphic position x on the genome, in samples i and j as:
Only lung, liver and spleen sites with more than two samples per site were included in the analysis. To normalize for different sampling efforts across sites, we first calculate the mean at each site (x axis; Fig. 3b ) or pairs of sites and then average across the site or pairs of sites. Error bars indicate the s.e.m. of the means across the sites or pairs of sites.
Transmission analysis. We developed an algorithm based on the number of shared mutations between sites (Fig. 4c) . Only genotypes found in two separate samples within an organ or lung site were considered to reduce the effects of potential cross-contamination. We iterated through mutations shared between the destination site and the rest of the lung. After each iteration, the genotype closest to the subject's MRCA containing a shared mutation was chosen and counted as a transmission event. All mutations in that genotype were removed from the list of unaccounted-for shared mutations, and the next iteration was performed. In this way, groups of mutations appearing on the same branch of the phylogeny were counted only as a single transmitted genotype. Finally, the presence of the subject's MRCA in both locations suggests a transmission of this ancestral genotype (Fig. 4c) . Simulations were performed to normalize for different sampling efforts across sites and organs, omitting one site from the lung each trial (for estimations of intra-organ transfer, this omitted site was then treated as destination). Only sites with more than six samples were included, and each site was randomly subsampled, taking the minimum number of samples across sites with >6 samples. For each omitted lung site, 1,000 trials were performed and averaged.
Code availability. Custom MATLAB code used for calling mutations and analyzing the data can be found at https://github.com/kishonylab/TB-diversity-across-organs.
